{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:04:54Z","timestamp":1789621494346,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gut microbiota, bile acid metabolism, and their derived metabolites are critical regulators of intestinal inflammation in inflammatory bowel disease (IBD). While microRNA-29a (miR-29a) is a recognized epigenetic regulator of intestinal inflammation, its role in shaping microbiota-driven bile acid metabolism, particularly secondary bile acid production, remains unclear. This study aimed to investigate how miR-29a regulates microbiota-bile acid axis, with an emphasis on lithocholic acid (LCA) and its anti-inflammatory effects in colitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Colitis was induced in wild-type and\n                      <jats:italic>Mir29a\/Mir29b-1<\/jats:italic>\n                      locus-deficient mice using dextran sulfate sodium (DSS), and disease severity, colonic injury, and inflammatory responses were assessed. Fecal microbiota composition and bile acid profiles were characterized using 16S rRNA gene sequencing and targeted metabolomics. Alterations in bile acids were further examined in relation to disease severity.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , Caco-2 cells were used to evaluate the anti-inflammatory effects of LCA under modulation of miR-29a expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MiR-29a\/b1 deficiency significantly exacerbated DSS-induced disease severity, colonic injury, inflammatory responses, and epithelial ultrastructural damage. KO-DSS mice exhibited gut microbiota dysbiosis, with reduced microbial diversity and altered community structure. Targeted metabolomics revealed impaired primary-to-secondary BA biotransformation, characterized by chenodeoxycholic acid (CDCA) accumulation and a reduced LCA\/CDCA ratio.\n                      <jats:italic>In vitro<\/jats:italic>\n                      , LCA supplementation attenuated DSS-induced pro-inflammatory gene expression, whereas this protective effect was partially diminished by miR-29a inhibition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results support a role for miR-29a in maintaining gut microbial bile acid homeostasis during colitis and contributing to the epithelial anti-inflammatory response to LCA. Together, these findings link host microRNA regulation to microbiota-derived BA function and may inform future precision strategies for IBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1867553","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:47:20Z","timestamp":1789620440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xi","family":"Xiao","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Postdoctoral Research Station, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gong","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexia","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine (TCM) and Rehabilitation Science, Guangdong Chaozhou Health Vocational College","place":["Chaozhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Wingngaiyuen Chinese Medicine Clinic","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Shao","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Oncology, The Affiliated Traditional Chinese Medicine (TCM) Hospital of Guangzhou Medical University, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Breast, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Cai","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176119","article-title":"Emerging therapies in inflammatory bowel disease: a comprehensive review","volume":"14","author":"Appiah","year":"2025","journal-title":"J. Clin. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ecco-jcc\/jjaa175","article-title":"Ten reasons to think about bile acids in managing inflammatory bowel disease","volume":"15","author":"Camilleri","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","article-title":"Database resources of the national genomics data center, China National Center for bioinformation in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1038\/s41467-024-52113-y","article-title":"HIF-2\u03b1-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis","volume":"15","author":"Czopik","year":"2024","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-026-00859-9","article-title":"Microbiota-derived metabolite landscapes modulate Fusobacterium fitness and colorectal cancer cell behaviour","author":"Dhiman","year":"2026","journal-title":"Gut Pathog"},{"key":"B7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","article-title":"Bile acid signaling in inflammatory bowel diseases","volume":"66","author":"Fiorucci","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.omtn.2018.07.007","article-title":"The supercarbonate apatite-microRNA complex inhibits dextran sodium sulfate-induced colitis","volume":"12","author":"Fukata","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/pr.2018.14","article-title":"Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis","volume":"83","author":"Huang","year":"2018","journal-title":"Pediatr. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.7150\/ijbs.59904","article-title":"Roles of microRNAs in inflammatory bowel disease","volume":"17","author":"Jung","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41575-025-01097-1","article-title":"The global burden of inflammatory bowel disease: from 2025 to 2045","volume":"22","author":"Kaplan","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","article-title":"The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon","volume":"56","author":"Kong","year":"2023","journal-title":"Immunity"},{"key":"B15","first-page":"177","article-title":"Nanotherapeutics: restoring gut-dysbiosis and inducing cancer apoptosis","volume-title":"Spatially Variable Genes in Cancer: Development, Progression, and Treatment Response","author":"Kumar","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1124\/mol.110.068247","article-title":"Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells","volume":"80","author":"Li","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20240363","article-title":"MiR-29a\/b suppresses CD8+ T cell effector function and intestinal inflammation","volume":"5","author":"Lin","year":"2025","journal-title":"Exploration"},{"key":"B19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"B20","first-page":"8542","article-title":"miR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1","volume":"7","author":"Lv","year":"2014","journal-title":"Int. J. Clin. Exp. Path."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","article-title":"Gut microbiota Turicibacter strains differentially modify bile acids and host lipids","volume":"14","author":"Lynch","year":"2023","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12094-022-02978-6","article-title":"MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer","volume":"25","author":"Mo","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1073\/pnas.1005066107","article-title":"Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid","author":"Mohamadzadeh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1042\/CS20140048","article-title":"In Crohn\u2019s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts","volume":"127","author":"Nijhuis","year":"2014","journal-title":"Clin. Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114175","article-title":"MiR-29a-loaded nanoparticles alleviate inflammatory bowel disease via Sgk1\/Foxo3a axis","volume":"387","author":"Niu","year":"2025","journal-title":"J. Control Release"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.3748\/wjg.v16.i33.4135","article-title":"Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome","volume":"16","author":"Nossa","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2356284","article-title":"Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis","volume":"16","author":"Pan","year":"2024","journal-title":"Gut Microbes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/ndt\/gfx060","article-title":"Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis","volume":"32","author":"Panizo","year":"2017","journal-title":"Nephrol. Dial Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2859-6-22","article-title":"Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice","volume":"6","author":"Rochat","year":"2007","journal-title":"Microb. Cell Fact."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.862974","article-title":"Galactooligosaccharide treatment alleviates DSS-induced colonic inflammation in Caco-2 cell model","volume":"9","author":"Roselli","year":"2022","journal-title":"Front. Nutr."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154751","article-title":"MiRNA-based regulation of hemostatic factors through hepatic nuclear factor-4 alpha","volume":"11","author":"Salloum-Asfar","year":"2016","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1194\/jlr.M004531","article-title":"A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes","volume":"51","author":"Song","year":"2010","journal-title":"J. Lipid Res."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2026.189563","article-title":"Gut-liver axis drives the triple mechanism of liver inflammation-carcinogenesis: microbial-immune-metabolic network","volume":"1881","author":"Sun","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829525","article-title":"The emerging role of bile acids in the pathogenesis of inflammatory bowel disease","volume":"13","author":"Thomas","year":"2022","journal-title":"Front. Immunol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082726","article-title":"Dextran sodium sulfate-induced impairment of protein trafficking and alterations in membrane composition in intestinal Caco-2 cell line","volume":"21","author":"Toutounji","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2829","article-title":"Purification of total RNA from DSS-treated murine tissue via lithium chloride precipitation","volume":"8","author":"Viennois","year":"2018","journal-title":"Bio Protoc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"G550","DOI":"10.1152\/ajpgi.00256.2016","article-title":"Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon","volume":"312","author":"Ward","year":"2017","journal-title":"Am. J. Physiology-Gastrointestinal Liver Physiol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01084","article-title":"Mechanism of hydrophobic bile acid-induced hepatocyte injury and drug discovery","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093143","article-title":"Bile acid-gut microbiota axis in inflammatory bowel disease: from bench to bedside","volume":"13","author":"Yang","year":"2021","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzaf072","article-title":"The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data","volume":"23","author":"Zhang","year":"2025","journal-title":"Genomics Proteomics Bioinf."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3762591","article-title":"Qu-Yu-Jie-Du decoction ameliorates dextran sulfate sodium-induced colitis in mice by modulation of neutrophils and macrophage infiltration","volume":"2022","author":"Zhao","year":"2022","journal-title":"Evid Based Complement Alternat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2014.09.037","article-title":"MicroRNA 29 targets nuclear factor-\u03baB-repressing factor and Claudin 1 to increase intestinal permeability","volume":"148","author":"Zhou","year":"2015","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.bbrc.2019.02.126","article-title":"MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7","volume":"511","author":"Zhu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1867553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:47:26Z","timestamp":1789620446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1867553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":47,"alternative-id":["10.3389\/fcimb.2026.1867553"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1867553","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1867553"}}